Evaluation of the antimalarial potential of Icacina senegalensis Juss (Icacinaceae)  by David-Oku, Essien et al.
S469
Document heading          doi: 10.1016/S1995-7645(14)60276-5
Evaluation of the antimalarial potential of Icacina senegalensis Juss 
(Icacinaceae)  
Essien David-Oku1*, Obiajunwa-Otteh Juliet Ifeoma1, Akuodor Godwin Christian2, Essien Augustine Dick2 
1Department of Biochemistry, College of Medical Sciences, University of Calabar, Nigeria
2Department of Pharmacology, College of Medical Sciences, University of Calabar, Nigeria
Asian Pac J Trop Med 2014; 7(Suppl 1): S469-S472
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
    *Corresponding author: Dr. Essien David-Oku, Department of Biochemistry, College 
of Medical Sciences, University of Calabar, Nigeria.
     Tel: +2348056937775
     E-mail: drdavidoku@yahoo.co.uk
     
1. Introduction
   Malaria is the world most important parasitic infection 
and it remains a major impediment to health in Africa, 
south of the Sahara[1]. The present global situation indicates 
a recent insurgence in the severity of the disease and that 
malaria could still be described as one of the most important 
communicable diseases, with an annual incidence of 300-500 
million clinically manifestated cases and a death toll of 1-2 
million people[2,3]. One area for search for new antimalarials 
is the traditionally claimed antimalarial plants from African 
flora[4]. Plant forms the major parts of treatments used by 
traditional healers in many societies, thus many plants have 
acquired reputation for being useful against malaria. Studies 
have been conducted on traditionally claimed medicinal 
plant in Nigeria for scientific validation[5]. This is because 
they have been part of human life, and a number of plant 
products have been in extensive use in ethnomedicine.
   Icacina senegalensis A. Juss (Family: Icacinaceae) (I. 
senegalensis) is a savannah suffurex with glabrous or 
pubescent leafy shoots of about 2-3 feet high and a large 
fleshy tuber with creeping roots. The plant is indigenous to 
West and Central Africa[6,7]. It grows wild on light sandy soils 
in the savannah areas of Senegal, Gambia, Ghana, Nigeria, 
Guinea, Central African Republic, Congo and parts of Sudan. 
Different parts of the plant, especially the leaves, root and 
stem are widely employed in traditional medicine. The 
leaves are taken as a decoction for feverish condition. Extract 
of the leaves in water or diluted alcohol has been used as 
antihyperglycemic agent[8]. 
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   The present study was aimed at evaluating the antimalarial 
activity of methanol leaf extract of I. senegalensis on 
Plasmodium berghei (P. berghei) infected mice.
2. Materials and methods
2.1. Collection and preparation of plant materials
   Fresh leaves of I. senegalensis were collected in July, 2012 
from a farm land in Orlu, Imo State, Nigeria. The plant material 
was identified and authenticated by Mr Frank I. Akpejoye of 
Department of Botany, University of Calabar, where a voucher 
specimen (No. 620) is maintained. The leaves were cleaned, 
cut into smaller pieces, air-dried at room temperature for 7 d 
and pulverized to dry powder using a mortar and pestle.
2.2. Extraction of plant material
   Eighty grams of the leaf powder was extracted in a Soxhlet 
extractor for 24 h. The mixture was concentrated to dryness 
in a water bath to obtain 5 g (6% w/w) of methanol extract. The 
leaf extract was subsequently reconstituted in an appropriate 
volume of Tween 80 (2% v/v) for use on each day. 
2.3. Phytochemical analysis
   The phytochemical screening of methanol extract of I. 
senegalensis leaf was carried out to determine the presence 
of the following compounds: alkaloids, tannins, saponins, 
terpenoides, phlobatannins, flavonoids, steroids, cardiac 
glycosides, phenols and anthraquinones using standard 
procedures[9-11].
2.4. Animals
   Swiss albino mice (20-25 g) of both sexes obtained from 
Animal House, Department of Biochemistry, College of 
Medical Sciences, University of Calabar, Nigeria, were used 
for the study. The animals were housed in cages at room 
temperature and moisture, under naturally illuminated 
environment of 12:12 h dark/light cycle. They were fed on 
standard diet and had free access to water.
2.5. Acute toxicity study of the extract
   The LD50 of the methanol leaf extract was tested to determine 
the safety of the agent using Ravinchandran method[12]. Dose 
levels used were 10, 100, 1 000 and 2 000 mg/kg. All the doses 
were administered orally. The mice were observed for signs 
of toxicity which includes: paw licking, salivation, stretching 
of the entire body, weakness, respiratory distress, coma and 
death for 72 h.
2.6. Malaria parasites
   The chloroquine sensitive P. berghei (NK65) was obtained 
from National Institute for Medical Research, Lagos, Nigeria 
and kept at the Department of Pharmacology, College 
of Medical Sciences, University of Calabar, Nigeria. The 
parasites were maintained by continuous re-infestation in 
mice.
2.7. Inocula 
   Parasitized erythrocytes were obtained from a donor 
infected mouse by cardiac puncture. This was prepared 
for determining both the percentage parasitemia and the 
erythrocytes count of the donor mouse and they were 
diluted with normal saline in proportions indicated by 
both determinations[13]. Each mouse was inoculated 
intraperitoneally with infected blood suspension (0.2 mL) 
containing 1伊107 P. berghei parasitized red blood cells.
2.8. Suppressive test
   A 4-day suppressive test as described by Akuodor et al.[14] 
and Mbah et al.[15] was employed for the study. Thirty Swiss 
albino mice of both sexes weighing (20-25 g) were passed 
intraperitoneally with standard inoculums of P. berghei 
containing 1伊107 infected erythrocytes. After 3 h, the infected 
mice were randomly divided into 5 groups of 6 per cage and 
treated for four consecutive days (D0-D3) with 25, 50 and 100 
mg/kg of the methanol leaf extract, chloroquine diphosphate 
(10 mg/kg) and 0.2 mL of Tween 80 (control), all the treatments 
were administered orally. On the fifth day, thin films were 
made from the tail blood of each mouse. The films were fixed 
with methanol, stained with Giemsa and parasitemia density 
examined by microscopically (CX 21 Japan) counting the 
parasitized red blood cells on at least 1 000 red blood cells in 
10 different fields[16].
2.9. Curative test
   On the first day (D0), thirty Swiss albino mice were passed 
intraperitoneally with standard inoculums of 1伊107 P. berghei 
infected erythrocytes. After 72 h, the mice were randomly 
divided into 5 groups of 6 each and treated with 25, 50 and 
100 mg/kg of the leaf extract, chloroquine diphosphate (10 
mg/kg) and 0.2 mL of Tween 80 (control), all the treatment 
were administered orally. Treatment continued daily until 
the seventh day when thin films were made from the tail 
blood of each mouse. The films were fixed with methanol, 
stained with Giemsa and parasitemia density examined by 
microscopically counting the parasitized red blood cells 
on at least 1 000 red blood cells in 10 different fields[16]. 
The mean survival time of each group was determined by 
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finding the average survival time (days) of the mice in each 
group over a period of 30 d (D0-D29). 
2.10. Statistical analysis
   Results obtained were expressed as mean+SEM. Data were 
analysed using One-way ANOVA and differences between the 
means were considered significant at P<0.05.
3. Results 
3.1. Phytochemical tests
   The results of phytochemical screening of the methanol 
leaf extract of I. senegalensis revealed the presence of 
alkaloids, saponins, tannins, terpenoids, flavonoids, phenols, 
steroids and cardiac glycosides, while phlobatannins and 
anthraquinones were absent.
3.2. Acute toxicity test 
   The LD50 of the methanol leaf extract was greater than 
2 000 mg/kg p.o. in mice. Abdominal constriction and 
hyperactivity were observed as the signs of toxicity.
3.3. Suppressive effect
   The methanol leaf extract exhibited a dose-dependent 
effect at different doses employed. Doses of 25.0, 50.0 and 
100.0 mg/kg caused 64%, 74% and 80% inhibition of parasitemia 
respectively. The effect of the extract was significantly 
(P<0.05) when compared with the control. The reference drug, 
chloroquine (10 mg/kg), caused 92% suppression (Table 1).
Table 1 
Suppressive effect of methanol leaf extract of I. senegalensis against P. 
berghei in mice. 
Drug                      Dose Parasitemia density (D5) % Suppression
Tween 80                                  0.2 mL 32.92依0.65 -
I. senegalensis                 25.0 mg/kg 11.80依0.55  64*
  50.0 mg/kg   9.78依0.32  70*
  100.0 mg/kg    6.52依0.30     80*
Chloroquine                         10.0 mg/kg   2.63依0.32        92*
D5=Day 5, 
*: Significantly different from control at P<0.05.
3.4. Curative effect
   The methanol leaf extract caused a dose-dependent 
reduction in parasitemia in the extract treated groups similar 
to chloroquine treated unlike the Tween 80 in which there 
was a consistent increase in the blood parasite density. The 
survival values showed that the extract significantly (P<0.05) 
suppressed established infection at the doses employed. 
Death was observed in the control group on Day 11 and by Day 
15, all mice in the group died. On the other hand, mice in the 
extract treated groups survived beyond 24 d. However, some of 
the mice in the 100 mg/kg group survived the 30 d observation 
period, while chloroquine treated group recorded no death at 
all (Table 2).
Table  2
Curative effect of methanol leaf extract of I. senegalensis against P. berghei in 
mice. 





Mean survival time 
(d)
Tween 80                   0.2 mL 32.08依0.47 41.70依0.34          15.00依1.69
I. senegalensis    25.0 mg/kg 30.27依0.53  14.75依0.16 24.50依2.58*
  50.0 mg/kg 29.40依0.66 12.65依0.53 27.33依1.76*
100.0 mg/kg 30.03依0.55 11.71依0.38   29.00依0.68*
Chloroquine           10.0 mg/kg 29.65依0.55    4.55依0.58    30.00依0.00*
D3=Day 3, D7=Day 7, 
*: Significantly different from control at P<0.05. 
4. Discussion
   The results showed that the methanol leaf extract of I. 
senegalensis possessed antiplasmodial activity that was 
evident from the chemosuppression produced during the 
4-day early infection study. This method of suppressive 
testing for antimalarial activity has become popular during 
scientific evaluation of potential phytomedicines for treatment 
of experimental malaria[3]. A mean group parasitemia levels 
of less or equal to 90% of the mock-treated control animals 
usually indicate that the test agent is active in standard 
screening studies[17]. Therefore, it is clear from the result that 
in P. berghei infected mice treated with I. senegalensis, the 
percentage of parasitemia measured changed significantly 
from those in the control animals.
   Our investigation of the scientific reasons behind the 
folkloric use of I. senegalensis in the treatment of malaria 
attack in traditional African setting can be partially satisfied 
with this result[18]. In addition, the result of chemosuppressive 
study can be interpreted to be that the leaf extract of this 
plant can suppress parasite growth to non-detectable levels 
in erythrocytes. It is important that scientific evaluation of 
traditional medicine preparations for claimed antimalarial 
efficacy can be carried out even up to the level of finding 
out the degree of suppression of growth in erythrocytes[19]. 
The plant extract also exerted significant curative activity 
during established infection. Curative activity of potential 
antimalarial agents of ethnobotanical materials should be 
discernible during testing for antimalarial properties[13]. The 
observed antimalarial activity of the leaf extract is consistent 
with the traditional use of the plant as herbal medication 
against the disease and indicative of its potential as a 
chemotherapeutic antimalarial agent. This was confirmed by 
the mean survival time values particularly in the group treated 
with 100 mg/kg of the extract. The fact that some of the mice in 
this group survived throughout 30 d of observation similar to 
the chloroquine-treated group shows a high level of efficacy.
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   However, the traditional use of I. senegalensis could be 
attributed to the presence of certain phytochemicals that 
constitute the bioactive principles in the plant. Numerous 
plants containing a wide variety of phytochemicals as their 
bioactive principle have shown antiplasmodial activities[20-
22]. The antiplasmodial activity of this plant extract might 
be attributed to the presence of alkaloids, flavonoids 
and terpenes which have been variously implicated in 
antiplasmodial activities of many plants[23].  
   The results of this have shown that the methanol leaf 
extract of I. senegalensis possesses antimalarial activity 
as seen in its ability to suppress chloroquine sensitive 
P. berghei infection in the two evaluated models. We 
recommend that further chemical studies should be done 
to identify, properly characterize and develop the actual 
compounds responsible for the observed activity. It is 
therefore hoped that the screening of locally used medicinal 
plants can fully be investigated with a view to establishing 
their efficacy and to determine their potential as sources of 
new antimalarial agents.
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